logofg

NON CLASSE
Our Key Actions

Our Key Actions

placeholder image
placeholder image
placeholder image

Test a cardiovascular screening tool for 50-year-old women on a panel of 1,000 women for three years. This project is supported by the Agence Régionale de Santé des Hauts de France, in partnership with the Union Régionale des Professionnels de Santé Libéraux, Associations de Cardiologie Nord Pas-de-Calais et Picardie and the Women’s Cardiovascular Healthcare Foundation (Agir pour le Cœur des Femmes). The future goal is for every woman in France—and eventually, around the world—to be screened at age 50. Develop an integrated care pathway that includes cardiologists, gynecologists, obstetricians, general practitioners, pharmacists and allied health professionals so women receive comprehensive care. These pathways will draw from the very positive results experienced with the Cœur Artères et Femmes (Heart, Arteries and Women) pathway led by Prof. Claire Mounier-Vehier, MD for the past 10 years. Promote cross-functional, epidemiological, clinical, foundational and social research projects that focus on the specifics of women’s cardiovascular health. Integrate training modules that specifically focus on cardiovascular disease in programs for health professionals and create practical, active prevention tools for all women so they can play a leading role in their own health. Run multichannel communication campaigns in all media, relying on social media in particular to share stories that help women understand the best ways to prevent cardiovascular disease, recognize the symptoms of a cardiovascular emergency and become prevention influencers by encouraging other women to take care of themselves. Host prevention and mobilization conferences for the general public, health professionals and the political and financial sectors in France and internationally.

 

SEE ALSO

placeholder

How Drug Tolerance Differs for Women

Health Professionals

This is the main conclusion of a large American study just published in Biology of Sex Differences, which analyzed literature data from more than 5,400 references to determine whether gender differences in pharmacokinetic parameters predict differences in the occurrence of adverse events in men and [...]

READ MORE

placeholder

What’s New in the 2020 European Recommendations on Atrial Fibrillation?

Publications

Epidemiology AF is a burden that is estimated to affect between two and four percent of the adult population These numbers are constantly increasing all around the world, which poses a growing problem for health systems. As an example, in Europe, it’s estimated that a 55-year-old individual [...]

READ MORE

placeholder

Expert consensus from SFHTA on Hormones, Hypertension and Women

Publications

French Society of Hypertension has established a partnership with Women’s Cardiovascular Healthcare Foundation to alert women with high blood pressure at three key hormone stages. A tangible application of this partnership, the expert consensus entitled “HTA, Hormone et Femmes” (Hypertension, [...]

READ MORE

 Your gift improves
prevention for women at key moments in their lives